Evidence map›Paper›PMID 34168128›Full record

ArticleNature communications2021

Residue 6.43 defines receptor function in class F GPCRs.

Ainoleena Turku, Hannes Schihada, Pawel Kozielewicz, Carl-Fredrik Bowin, Gunnar Schulte

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
1.9field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 31 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. GPCR Sense Communication Among Interaction Nematodes with Other Organisms.International journal of molecular sciences · 2025
    Review
  11. Article
  12. Review
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. GPCR activation mechanisms across classes and macro/microscales.Nature structural & molecular biology · 2021
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 2 countries.

Ainoleena TurkuKarolinska Institutet, Department of Physiology & Pharmacology, Sec. Receptor Biology & Signaling, Biomedicum 6D, Stockholm, Sweden.ORCID 0000-0003-0959-7221
Hannes Schihada *Karolinska Institutet, Department of Physiology & Pharmacology, Sec. Receptor Biology & Signaling, Biomedicum 6D, Stockholm, Sweden.
Pawel Kozielewicz *Karolinska Institutet, Department of Physiology & Pharmacology, Sec. Receptor Biology & Signaling, Biomedicum 6D, Stockholm, Sweden.ORCID 0000-0003-1414-3566
Carl-Fredrik BowinKarolinska Institutet, Department of Physiology & Pharmacology, Sec. Receptor Biology & Signaling, Biomedicum 6D, Stockholm, Sweden.ORCID 0000-0001-9090-9493
Gunnar SchulteKarolinska Institutet, Department of Physiology & Pharmacology, Sec. Receptor Biology & Signaling, Biomedicum 6D, Stockholm, Sweden. gunnar.schulte@ki.se.ORCID 0000-0002-2700-7013
Karolinska Institutet · SE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The class Frizzled of G protein-coupled receptors (GPCRs), consisting of ten Frizzled (FZD

Indexed as

Binding SitesBioluminescence Resonance Energy Transfer TechniquesBoron CompoundsCryoelectron MicroscopyCyclic AMP-Dependent Protein KinasesFrizzled ReceptorsHumansMolecular Dynamics SimulationMutationPhosphoproteinsProtein ConformationSmoothened ReceptorVeratrum Alkaloids4,4-difluoro-4-bora-3a,4a-diaza-s-indaceneBoron CompoundsCyclic AMP-Dependent Protein KinasescyclopamineFrizzled ReceptorsPhosphoproteinsSmoothened ReceptorSMO protein, humanVeratrum Alkaloids

Identifiers

PMID34168128
PMCPMC8225760
OpenAlexW3177133204

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.